Header Image Multifield: 
Header Image: 
Support our ovarian cancer appeal
Header Image: 
Animation still image
Header Image: 
Three scientists photographed in a laboratory

Welcome to WEHI

Super Content: 
The Brain Cancer Centre researchers

The Brain Cancer Centre

Many minds. One focus.

The Brain Cancer Centre was launched publicly on 25 October 2021. The centre was founded by Carrie’s Beanies 4 Brain Cancer and established in partnership with WEHI with support from the Victorian Government. 

The Brain Cancer Centre brings together the best and brightest minds with a single focus: to improve outcomes for brain cancer patients NOW and in the future. Our world-class research teams will work collaboratively to develop new treatments and trials so that patients diagnosed with brain cancer are given real hope.

Learn more


‘A 3D surface representation showing the inhibitor WM382 (in green) bound within the active site cleft of the pacman’s mouth, the plasmepsinX ( in grey). This event blocks the ability of plasmepsinX to process other parasite proteins required for the entry and exit of red blood cells. World-first 3D insights into malaria parasites strengthen drug discovery pipeline

Revolutionary 3D images have enabled researchers to understand how new anti-malaria compounds kill malaria parasites, paving the way for the next generation anti-malarial treatments. 

16 May 2022
read more
Dr Paola Favuzza will spend a year at MMV in Switzerland as part of the fellowship Fellowship to boost Australia’s drug discovery capabilities

WEHI’s Dr Paola Favuzza has received an MTPConnect Researcher Exchange and Development within Industry (REDI) fellowship, that will provide her with the vital industry experience required to turn basic scientific research into positive outcomes for patients. 

13 May 2022
read more
Antibodies binding the SARS-CoV-2 virus. This research could help reduce the severity of viruses like COVID-19 in the future Sweet discovery could drive down inflammation, cancers and viruses

A WEHI-led study has identified a new enzyme involved in controlling cell death, in findings that could lead to better treatment options for a range of inflammatory conditions, cancers and viruses.

12 May 2022
read more
Stephanie Studniberg and Associate Professor Diana Hansen New discovery to improve malaria elimination strategies

WEHI researchers have made a crucial discovery about how asymptomatic malaria infections impact the body, informing potential strategies to control transmission and improve treatment outcomes. 

4 May 2022
read more


Mon, 23/05/2022 - 11:00am to Mon, 23/05/2022 - 12:15pm

Pathways to the Clinic for Brain Cancer

Davis Auditorium

Tue, 24/05/2022 - 4:00pm to Tue, 24/05/2022 - 5:00pm

The origin of nuclear autoimmunity: nucleolin as an autoantibody target and a potential alarmin trigger

Davis Auditorium

Wed, 25/05/2022 - 1:00pm to Wed, 25/05/2022 - 2:00pm

Adventures in nanopore sequencing: developing new tools for exploring methylation and isoform expression in development and cancer

Davis Auditorium

Thu, 26/05/2022 - 3:30pm to Thu, 26/05/2022 - 4:30pm

NAD replenishment therapy in Parkinson’s disease: A New Hope?